{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T03:25:50Z","timestamp":1791257150987,"version":"4.1.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2005,5,1]],"date-time":"2005-05-01T00:00:00Z","timestamp":1114905600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,5,1]],"date-time":"2005-05-01T00:00:00Z","timestamp":1114905600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2005,5]]},"DOI":"10.1016\/j.jneuroim.2005.01.016","type":"journal-article","created":{"date-parts":[[2005,3,11]],"date-time":"2005-03-11T11:20:28Z","timestamp":1110540028000},"page":"157-164","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":56,"title":["Severity of Guillain\u2013Barr\u00e9 syndrome is associated with Fc\u03b3 Receptor III polymorphisms"],"prefix":"10.1016","volume":"162","author":[{"given":"Nina M.","family":"van Sorge","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.-Ludo","family":"van der Pol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc D.","family":"Jansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin P.W.","family":"Geleijns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Kalmijn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard A.C.","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy H.","family":"Rees","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Pritchard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian A.","family":"Vedeler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kjell-Morten","family":"Myhr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Shaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivo N.","family":"van Schaik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John H.J.","family":"Wokke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pieter A.","family":"van Doorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart C.","family":"Jacobs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan G.J.","family":"van de Winkel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonard H.","family":"van den Berg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2005.01.016_bib1","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1002\/ana.410270707","article-title":"Assessment of current diagnostic criteria for Guillain\u2013Barr\u00e9 syndrome","volume":"27","author":"Asbury","year":"1990","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2005.01.016_bib2","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1046\/j.1365-2249.1996.33740.x","article-title":"Fc gamma RIIa polymorphism in systemic lupus erythematosus (SLE): no association with disease","volume":"104","author":"Botto","year":"1996","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jneuroim.2005.01.016_bib3","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1182\/blood.V99.3.754","article-title":"Therapeutic activity of humanized anti-CD20 monoclonal antibody and polymorphism in IgG Fc receptor FcgammaRIIIa gene","volume":"99","author":"Cartron","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.jneuroim.2005.01.016_bib4","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1212\/WNL.59.12_suppl_6.S13","article-title":"Mechanisms of action of IVIg and therapeutic considerations in the treatment of acute and chronic demyelinating neuropathies","volume":"59","author":"Dalakas","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2005.01.016_bib5","doi-asserted-by":"crossref","first-page":"9772","DOI":"10.1073\/pnas.171308498","article-title":"Identification of a family of Fc receptor homologs with preferential B cell expression","volume":"98","author":"Davis","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jneuroim.2005.01.016_bib6","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1182\/blood.V86.6.2403.bloodjournal8662403","article-title":"Neutrophil Fc gamma RIIIb deficiency, nature, and clinical consequences: a study of 21 individuals from 14 families","volume":"86","author":"de Haas","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.jneuroim.2005.01.016_bib7","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1002\/art.10438","article-title":"Genetic linkage and association of Fcgamma receptor IIIA (CD16A) on chromosome 1q23 with human systemic lupus erythematosus","volume":"46","author":"Edberg","year":"2002","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jneuroim.2005.01.016_bib8","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1046\/j.1365-2249.2000.01208.x","article-title":"The role of Fcgamma receptor polymorphisms and C3 in the immune defence against Neisseria meningitidis in complement-deficient individuals","volume":"120","author":"Fijen","year":"2000","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jneuroim.2005.01.016_bib9","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0165-5728(00)00270-8","article-title":"Flow cytometric analysis of infiltrating cells in the peripheral nerves in experimental allergic neuritis","volume":"108","author":"Fujioka","year":"2000","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2005.01.016_bib10","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/S0140-6736(99)07202-5","article-title":"Association studies of genetic polymorphisms and complex disease","volume":"355","author":"Gambaro","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.jneuroim.2005.01.016_bib11","doi-asserted-by":"crossref","first-page":"S64","DOI":"10.1002\/ana.410270717","article-title":"Macrophage responses in inflammatory demyelinating neuropathies","volume":"27","author":"Griffin","year":"1990","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2005.01.016_bib12","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1002\/ana.410440512","article-title":"Electrophysiological classification of Guillain\u2013Barr\u00e9 syndrome: clinical associations and outcome. Plasma Exchange\/Sandoglobulin Guillain\u2013Barr\u00e9 Syndrome Trial Group","volume":"44","author":"Hadden","year":"1998","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2005.01.016_bib13","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1212\/WNL.56.6.758","article-title":"Preceding infections, immune factors, and outcome in Guillain\u2013Barr\u00e9 syndrome","volume":"56","author":"Hadden","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2005.01.016_bib14","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1002\/ana.410270716","article-title":"T-cell and macrophage activation in experimental autoimmune neuritis and Guillain\u2013Barr\u00e9 syndrome","volume":"27","author":"Hartung","year":"1990","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2005.01.016_bib15","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/sj.gene.6363639","article-title":"Association of Fc gamma receptor IIIB, but not of Fc gamma receptor IIA and IIIA polymorphisms with systemic lupus erythematosus in Japanese","volume":"1","author":"Hatta","year":"1999","journal-title":"Genes Immun."},{"key":"10.1016\/j.jneuroim.2005.01.016_bib16","doi-asserted-by":"crossref","first-page":"S92","DOI":"10.1086\/513793","article-title":"Clinical and epidemiologic features of Guillain\u2013Barr\u00e9 syndrome","volume":"176","author":"Hughes","year":"1997","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jneuroim.2005.01.016_bib17","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/ana.410400209","article-title":"Campylobacter jejuni infections and anti-GM1 antibodies in Guillain\u2013Barr\u00e9 syndrome","volume":"40","author":"Jacobs","year":"1996","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2005.01.016_bib18","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1212\/WNL.51.4.1110","article-title":"The spectrum of antecedent infections in Guillain\u2013Barr\u00e9 syndrome: a case-control study","volume":"51","author":"Jacobs","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2005.01.016_bib19","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1172\/JCI114259","article-title":"In vivo handling of soluble complement fixing Ab\/dsDNA immune complexes in chimpanzees","volume":"84","author":"Kimberly","year":"1989","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jneuroim.2005.01.016_bib20","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1902\/jop.2000.71.9.1425","article-title":"The Fcgamma receptor genotype as a risk factor for generalized early-onset periodontitis in Japanese patients","volume":"71","author":"Kobayashi","year":"2000","journal-title":"J. Periodontol."},{"key":"10.1016\/j.jneuroim.2005.01.016_bib21","doi-asserted-by":"crossref","first-page":"4220","DOI":"10.1182\/blood.V94.12.4220","article-title":"Variant genotypes of the low-affinity Fcgamma receptors in two control populations and a review of low-affinity Fcgamma receptor polymorphisms in control and disease populations","volume":"94","author":"Lehrnbecher","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.jneuroim.2005.01.016_bib22","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0022-1759(00)00240-4","article-title":"A novel PCR-based method for direct Fc gamma receptor IIIa (CD16) allotyping","volume":"242","author":"Leppers-van de Straat","year":"2000","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.jneuroim.2005.01.016_bib23","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0165-5728(94)00190-Y","article-title":"IgG anti-GM1 antibodies from patients with acute motor neuropathy are predominantly of the IgG1 and IgG3 subclasses","volume":"58","author":"Ogino","year":"1995","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2005.01.016_bib24","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1056\/NEJM199511233332102","article-title":"Campylobacter jejuni infection and Guillain\u2013Barr\u00e9 syndrome","volume":"333","author":"Rees","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jneuroim.2005.01.016_bib25","doi-asserted-by":"crossref","first-page":"2877","DOI":"10.1172\/JCI117994","article-title":"Fc gamma receptor IIIb enhances Fc gamma receptor IIa function in an oxidant-dependent and allele-sensitive manner","volume":"95","author":"Salmon","year":"1995","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jneuroim.2005.01.016_bib26","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1136\/ard.56.12.744","article-title":"Fc gamma RIIa polymorphism in systemic lupus erythematosus","volume":"56","author":"Smyth","year":"1997","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jneuroim.2005.01.016_bib27","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1056\/NEJM199204233261705","article-title":"A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain\u2013Barr\u00e9 syndrome. Dutch Guillain\u2013Barr\u00e9 Study Group","volume":"326","author":"van der Meche","year":"1992","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jneuroim.2005.01.016_bib28","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/s002510050426","article-title":"IgG receptor polymorphisms: risk factors for disease","volume":"48","author":"van der Pol","year":"1998","journal-title":"Immunogenetics"},{"key":"10.1016\/j.jneuroim.2005.01.016_bib29","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1212\/WNL.54.8.1661","article-title":"IgG receptor IIa alleles determine susceptibility and severity of Guillain\u2013Barr\u00e9 syndrome","volume":"54","author":"van der Pol","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2005.01.016_bib30","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1007\/s00251-003-0574-9","article-title":"Evidence for non-random distribution of Fcgamma receptor genotype combinations","volume":"55","author":"van der Pol","year":"2003","journal-title":"Immunogenetics"},{"key":"10.1016\/j.jneuroim.2005.01.016_bib31","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1002\/ana.10503","article-title":"Anti-GM1 IgG antibodies induce leukocyte effector functions via Fcgamma receptors","volume":"53","author":"Van Sorge","year":"2003","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2005.01.016_bib32","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1034\/j.1399-0039.2003.00037.x","article-title":"FcgammaR polymorphisms: implications for function, disease susceptibility and immunotherapy","volume":"61","author":"Van Sorge","year":"2003","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.jneuroim.2005.01.016_bib33","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S1568-9972(03)00089-2","article-title":"Pathogenicity of anti-ganglioside antibodies in the Guillain\u2013Barr\u00e9 syndrome","volume":"3","author":"van Sorge","year":"2004","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jneuroim.2005.01.016_bib34","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1212\/WNL.55.5.705","article-title":"IgG Fc-receptor polymorphisms in Guillain\u2013Barr\u00e9 syndrome","volume":"55","author":"Vedeler","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2005.01.016_bib35","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0165-5728(01)00344-7","article-title":"Fc receptors for immunoglobulin G\u2014a role in the pathogenesis of Guillain\u2013Barr\u00e9 syndrome and multiple sclerosis","volume":"118","author":"Vedeler","year":"2001","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2005.01.016_bib36","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1007\/BF02602657","article-title":"Fine mapping of the human pentraxin gene region on chromosome 1q23","volume":"44","author":"Walsh","year":"1996","journal-title":"Immunogenetics"},{"key":"10.1016\/j.jneuroim.2005.01.016_bib37","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.4049\/jimmunol.147.4.1338","article-title":"A single amino acid in the second Ig-like domain of the human Fc gamma receptor II is critical for human IgG2 binding","volume":"147","author":"Warmerdam","year":"1991","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2005.01.016_bib38","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1093\/brain\/awf272","article-title":"Peripheral neuropathies and anti-glycolipid antibodies","volume":"125","author":"Willison","year":"2002","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2005.01.016_bib39","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1172\/JCI119616","article-title":"A novel polymorphism of FcgammaRIIIa (CD16) alters receptor function and predisposes to autoimmune disease","volume":"100","author":"Wu","year":"1997","journal-title":"J. Clin. Invest."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572805000391?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572805000391?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:00:21Z","timestamp":1759046421000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572805000391"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,5]]},"references-count":39,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2005,5]]}},"alternative-id":["S0165572805000391"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2005.01.016","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2005,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Severity of Guillain\u2013Barr\u00e9 syndrome is associated with Fc\u03b3 Receptor III polymorphisms","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2005.01.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}